OxySure Earnings Presentation - 1Q2014 v2.pdf May. 2014 | Page 12

Statement of operations For the three months ended March 31, 2014 Revenues, net Cost of goods sold Gross profit $ 2013 356,229 205,590 150,639 $ 240,420 53,181 187,239 Operating expenses Research and development Sales and marketing Other general and administrative Loss from operations 1,541 87,949 345,757 (284,608) 36,711 107,347 256,617 (213,436) Other income (expenses) Gain on settlement of debt Other income (expense) Interest expense Total other income (expenses) 16,226 (331) (107,607) (91,712) (28,716) (28,716) Net loss Basic net income (loss) per common share Diluted net income (loss) per common share Weighted average common shares outstanding: Basic Diluted $ (376,320) $ (242,152) $ $ (0.01) (0.01) $ $ (0.01) (0.01) 25,889,334 25,889,334 23,036,157 23,036,157 12